BIOMAT Database Logo BIOMAT Database Logo

[Parkinsonism induced by sodium valproate]. 1995

M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Servicio de Neurología, Complejo Hospitalario de Ciudad Real.

Parkinsonism is a rare side effect of treatment with sodium valproate. We report 2 elderly women who developed parkinsonian syndrome several years after starting valproate therapy, and in whom symptoms disappeared when treatment was withdrawn. These cases, along with others in the literature, may support experimental evidence for the importance of GABAergic modulation in motor control.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004830 Epilepsy, Tonic-Clonic A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329) Epilepsy, Grand Mal,Epilepsy, Major,Grand Mal Seizure Disorder,Major Motor Seizure Disorder,Seizure Disorder, Tonic Clonic,Convulsions, Grand Mal,Cryptogenic Tonic-Clonic Epilepsy,Epilepsy, Tonic-Clonic, Cryptogenic,Epilepsy, Tonic-Clonic, Familial,Epilepsy, Tonic-Clonic, Symptomatic,Familial Tonic-Clonic Epilepsy,Seizure Disorder, Grand Mal,Seizure Disorder, Major Motor,Symptomatic Tonic-Clonic Epilepsy,Tonic Clonic Convulsions,Tonic-Clonic Convulsion Disorder,Tonic-Clonic Convulsion Syndrome,Tonic-Clonic Seizure Disorder,Tonic-Clonic Seizure Syndrome,Convulsion Disorder, Tonic-Clonic,Convulsion Disorders, Tonic-Clonic,Convulsion Syndrome, Tonic-Clonic,Convulsion Syndromes, Tonic-Clonic,Convulsion, Grand Mal,Convulsion, Tonic Clonic,Convulsions, Tonic Clonic,Cryptogenic Tonic Clonic Epilepsy,Cryptogenic Tonic-Clonic Epilepsies,Disorder, Tonic-Clonic Convulsion,Disorder, Tonic-Clonic Seizure,Disorders, Tonic-Clonic Convulsion,Disorders, Tonic-Clonic Seizure,Epilepsies, Cryptogenic Tonic-Clonic,Epilepsies, Familial Tonic-Clonic,Epilepsies, Symptomatic Tonic-Clonic,Epilepsies, Tonic-Clonic,Epilepsy, Cryptogenic Tonic-Clonic,Epilepsy, Familial Tonic-Clonic,Epilepsy, Symptomatic Tonic-Clonic,Epilepsy, Tonic Clonic,Familial Tonic Clonic Epilepsy,Familial Tonic-Clonic Epilepsies,Grand Mal Convulsion,Grand Mal Convulsions,Grand Mal Epilepsy,Major Epilepsies,Major Epilepsy,Seizure Disorder, Tonic-Clonic,Seizure Disorders, Tonic-Clonic,Seizure Syndrome, Tonic-Clonic,Seizure Syndromes, Tonic-Clonic,Symptomatic Tonic Clonic Epilepsy,Symptomatic Tonic-Clonic Epilepsies,Syndrome, Tonic-Clonic Convulsion,Syndrome, Tonic-Clonic Seizure,Syndromes, Tonic-Clonic Convulsion,Syndromes, Tonic-Clonic Seizure,Tonic Clonic Convulsion,Tonic Clonic Convulsion Disorder,Tonic Clonic Convulsion Syndrome,Tonic Clonic Seizure Disorder,Tonic Clonic Seizure Syndrome,Tonic-Clonic Convulsion Disorders,Tonic-Clonic Convulsion Syndromes,Tonic-Clonic Epilepsies,Tonic-Clonic Epilepsies, Cryptogenic,Tonic-Clonic Epilepsies, Familial,Tonic-Clonic Epilepsies, Symptomatic,Tonic-Clonic Epilepsy,Tonic-Clonic Epilepsy, Cryptogenic,Tonic-Clonic Epilepsy, Familial,Tonic-Clonic Epilepsy, Symptomatic,Tonic-Clonic Seizure Disorders,Tonic-Clonic Seizure Syndromes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
[Valproate induced parkinsonism].
January 1998, No to shinkei = Brain and nerve,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Reversible parkinsonism induced by prolonged treatment with valproate.
December 1998, Journal of neurology,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
[Reversible parkinsonism induced by prolonged treatment with valproate].
January 2002, Therapie,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Cutaneous vasculitis induced by sodium valproate.
February 1991, Lancet (London, England),
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Valproate-induced Parkinsonism in epilepsy patients.
January 2007, Movement disorders : official journal of the Movement Disorder Society,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Valproate-induced rest tremor and parkinsonism.
April 2021, Acta neurologica Belgica,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Diagnosis of Parkinsonism in older patients receiving sodium valproate.
June 2007, Movement disorders : official journal of the Movement Disorder Society,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Nicotinic acid deficiency induced by sodium valproate.
June 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Stevens - johnson syndrome induced by sodium valproate.
July 2004, Indian journal of psychiatry,
M A del Real Francia, and J Sanz Martínez, and J Vaamonde Gamo, and M Gudín Rodríguez-Magariños, and R Ibáñez Alonso, and V Riñón
Sodium Valproate-Induced Hyperpigmentation.
December 2023, The Journal of pediatrics,
Copied contents to your clipboard!